by FiveSenses | Feb 27, 2026 | News Release
Montreal, QC, Canada, February 27th, 2026 — Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the launch of a private... 
by FiveSenses | Feb 10, 2026 | News Release
Montreal, QC, Canada, February 10th, 2026 — Defence Therapeutics Inc. (“Defence” or the “Company”), a publicly traded biotechnology and precision intracellular drug-delivery company, reported on its Scientific Advisory Board (“SAB”) meeting held on January 30, 2026,... 
by FiveSenses | Feb 4, 2026 | News Release
Montreal, QC, Canada, February 4th, 2026 — Defence Therapeutics Inc. (“Defence” or the “Company”), a publicly traded biotechnology and precision intracellular drug-delivery company, today announced that it will present at World ADC Europe 2026, taking place February...
Recent Comments